Taking cues from launches so far in oncology and rheumatology, three important considerations for biosimilar marketability are outlined
Sonia T. Oskouei and Jeff Baldetti, Cardinal Health
Advertisement
Articles by Sonia T. Oskouei and Jeff Baldetti, Cardinal Health
Advertisement
Latest Updated Articles
Key learnings to support biosimilar commercialization in the USPublished: December 21st 2021 | Updated:
Advertisement
Advertisement
